Endotoxemia affects citrulline, arginine and glutamine bioavailability

European Journal of Clinical Investigation

Volumn 42, Issue 3, 2012, Pages 282-289

  Elwafi, Fatimazahra ^a   Curis, Emmanuel ^a   Zerrouk, Naima ^a   Neveux, Nathalie ^b,c   Chaumeil, Jean Claude ^a   Arnaud, Philippe ^a   Cynober, Luc ^b,c   Moinard, Christophe ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c HÔTEL DIEU   (France)

Author keywords

Citrulline; Oral administration; Pharmacokinetics; Sepsis

Indexed keywords

ARGININE; CITRULLINE; ENDOTOXIN; GLUTAMINE; LIPOPOLYSACCHARIDE; ORNITHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BIOTRANSFORMATION; CONTROLLED STUDY; ENDOTOXEMIA; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLITE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; AREA UNDER CURVE; ARGININE; BIOLOGICAL AVAILABILITY; CITRULLINE; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; GLUTAMINE; LIPOPOLYSACCHARIDES; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84856576823     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02581.x     Document Type: Article

References (48)

1. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003;168:165-72.
2. Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth 1996;77:110-7.
3. Vente JP, von Meyenfeldt MF, van Eijk HM, van Berlo CL, Gouma DJ, van der Linden CJ et al. Plasma-amino acid profiles in sepsis and stress. Ann Surg 1989;209:57-62.
4. Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE. Sepsis: an arginine deficiency state? Crit Care Med 2004;32:2135-45.
5. Suchner U, Kuhn KS, Furst P. The scientific basis of immunonutrition. Proc Nutr Soc 2000;59:553-63.
6. Popovic PJ, Zeh HJ 3rd, Ochoa JB. Arginine and immunity. J Nutr 2007;137:1681S-6S.
7. Osowska S, Moinard C, Neveux N, Loi C, Cynober L. Citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection. Gut 2004;53:1781-6.
8. Ligthart-Melis GC, van de Poll MC, Boelens PG, Dejong CH, Deutz NE, van Leeuwen PA. Glutamine is an important precursor for de novo synthesis of arginine in humans. Am J Clin Nutr 2008;87:1282-7.
9. Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Benazeth S et al. Almost all about citrulline in mammals. Amino Acids 2005;29:177-205.
10. Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol 2008;65:51-9.
11. Wijnands K.A., Vink H., Buurman W.A., Lamers W.H., Poeze M. Citrulline supplementation improves the microcirculation through the arginine-NO metabolism in sepsis. Int Care Med 2010;35:S89.
12. Husson A, Brasse Lagnel C., Fairand A., Renouf S., Lavoinne A. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem 2003;270:1887-99.
13. Xu DZ, Lu Q, Deitch EA. Nitric oxide directly impairs intestinal barrier function. Shock 2002;17:139-45.
14. Gardiner KR, Ahrendt GM, Gardiner RE, Barbul A. Failure of intestinal amino acid absorptive mechanisms in sepsis. J Am Coll Surg 1995;181:431-6.
15. Sodeyama M, Gardiner KR, Regan MC, Kirk SJ, Efron G, Barbul A. Sepsis impairs gut amino acid absorption. Am J Surg 1993;165:150-4.
16. Bistrian BR. Practical recommendations for immune-enhancing diets. J Nutr 2004;134:2868S-72S.
17. Cynober L. We must improve our understanding of the basic mechanisms of the different phases of sepsis. Clin Nutr 2008;27:311-2.
18. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186-96.
19. Neveux N, David P, Cynober L. Measurement of amino acid concentration in biological fluids and tissues using ion-exchange chromatography. In: Cynober LA, editor. Metabolic and Therapeutic Aspects of Amino Acids in Clinical Nutrition, 2nd edn. Boca Raton, FL: CRC Press, 2004: pp 17-28.
20. Team RDC. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2008.
21. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002;30:2022-9.
22. Wernerman J, Hammarqvist F. Glutamine: a necessary nutrient for the intensive care patient. Int J Colorectal Dis 1999;14:137-42.
23. Galban C, Montejo JC, Mesejo A, Marco P, Celaya S, Sanchez-Segura JM et al. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000;28:643-8.
24. Bruins MJ, Soeters PB, Lamers WH, Deutz NE. L-arginine supplementation in pigs decreases liver protein turnover and increases hindquarter protein turnover both during and after endotoxemia. Am J Clin Nutr 2002;75:1031-44.
25. Loi C, Zazzo JF, Delpierre E, Niddam C, Neveux N, Curis E et al. Increasing plasma glutamine in postoperative patients fed an arginine-rich immune-enhancing diet - a pharmacokinetic randomized controlled study. Crit Care Med 2009;37:501-9.
26. Wang Q, Wang JJ, Boyce S, Fischer JE, Hasselgren PO. Endotoxemia and IL-1 beta stimulate mucosal IL-6 production in different parts of the gastrointestinal tract. J Surg Res 1998;76:27-31.
27. Gardiner KR, Gardiner RE, Barbul A. Reduced intestinal absorption of arginine during sepsis. Crit Care Med 1995;23:1227-32.
28. Abad B, Mesonero JE, Salvador MT, Garcia-Herrera J, Rodriguez-Yoldi MJ. Tumor necrosis factor-alpha mediates inhibitory effect of lipopolysaccharide on L-leucine intestinal uptake. Dig Dis Sci 2002;47:1316-22.
29. Salloum RM, Copeland EM, Souba WW. Brush border transport of glutamine and other substrates during sepsis and endotoxemia. Ann Surg 1991;213:401-9.
30. Bahri S, Curis E, El Wafi FZ, Aussel C, Chaumeil JC, Cynober L et al. Mechanisms and kinetics of citrulline uptake in a model of human intestinal epithelial cells. Clin Nutr 2008;27:872-80.
31. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch 2004;447:532-42.
32. Closs EI, Simon A, Vekony N, Rotmann A. Plasma membrane transporters for arginine. J Nutr 2004;134:2752S-9S.
33. Bode BP. Recent molecular advances in mammalian glutamine transport. J Nutr 2001;131:2475S-85S.
34. Piton G, Manzon C, Monnet E, Cypriani B, Barbot O, Navellou JC et al. Plasma citrulline kinetics and prognostic value in critically ill patients. Intensive Care Med 2010;36:702-6.
35. Hattori Y, Shimoda S, Gross SS. Effect of lipopolysaccharide treatment in vivo on tissue expression of argininosuccinate synthetase and argininosuccinate lyase mRNAs: relationship to nitric oxide synthase. Biochem Biophys Res Commun 1995;215:148-53.
36. Nagasaki A, Gotoh T, Takeya M, Yu Y, Takiguchi M, Matsuzaki H et al. Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. RNA blot, immunoblot, and immunohistochemical analyses. J Biol Chem 1996;271:2658-62.
37. Yu YM, Ryan CM, Burke JF, Tompkins RG, Young VR. Relations among arginine, citrulline, ornithine, and leucine kinetics in adult burn patients. Am J Clin Nutr 1995;62:960-8.
38. Yu YM, Ryan CM, Castillo L, Lu XM, Beaumier L, Tompkins RG et al. Arginine and ornithine kinetics in severely burned patients: increased rate of arginine disposal. Am J Physiol Endocrinol Metab 2001;280:E509-17.
39. Hankard RG, Darmaun D, Sager BK, D'Amore D, Parsons WR, Haymond M. Response of glutamine metabolism to exogenous glutamine in humans. Am J Physiol 1995;269:E663-70.
40. Haque SM, Chen K, Usui N, Iiboshi Y, Okuyama H, Masunari A et al. Effects of endotoxin on intestinal hemodynamics, glutamine metabolism, and function. Surg Today 1997;27:500-5.
41. Souba WW, Herskowitz K, Klimberg VS, Salloum RM, Plumley DA, Flynn TC et al. The effects of sepsis and endotoxemia on gut glutamine metabolism. Ann Surg 1990;211:543-9.
42. Brand K, Leibold W, Luppa P, Schoerner C, Schulz A. Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism. Immunobiology 1986;173:23-34.
43. Ardawi MS, Majzoub MF, Kateilah SM, Newsholme EA. Maximal activity of phosphate-dependent glutaminase and glutamine metabolism in septic rats. J Lab Clin Med 1991;118:26-32.
44. Austgen TR, Chen MK, Dudrick PS, Copeland EM, Souba WW. Cytokine regulation of intestinal glutamine utilization. Am J Surg 1992;163:174-9.
45. Nose K, Wasa M, Okada A. Gut glutamine metabolism at different stages of sepsis in rats. Surg Today 2002;32:695-700.
46. Neilly PJ, Gardiner KR, Kirk SJ, O'Hare M, Jennings G, Anderson NH et al. Topical glutamine therapy in experimental inflammatory bowel disease. Clin Nutr 1995;14:283-7.
47. Moinard C, Cynober L. Citrulline: a new player in the control of nitrogen homeostasis. J Nutr 2007;137:1621S-5S.
48. Osowska S, Duchemann T, Walrand S, Paillard A, Boirie Y, Cynober L et al. Citrulline modulates muscle protein metabolism in old malnourished rats. Am J Physiol Endocrinol Metab 2006;291:E582-6.